![[Newsroom] Thumbnail GLP1 and AMD Story](https://piemagazine.org/wp-content/uploads/sites/4/2025/06/Newsroom-Thumbnail-GLP1-and-AMD-Story-579x326.png)
GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…
FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
Regeneron’s proposal to lengthen EYLEA HD dosing intervals to 24 weeks hits a CRL roadblock. The wait for extended treatment…
popular posts
latest posts